Calpain3 expression during human cardiogenesis. (Q52167913)

26 April 2018

title

Calpain3 expression during human cardiogenesis. (English)

1 reference

26 April 2018

author name string

Fougerousse F

1 reference

26 April 2018

Anderson LV

1 reference

26 April 2018

Delezoide AL

1 reference

26 April 2018

Suel L

1 reference

26 April 2018

Durand M

1 reference

26 April 2018

Beckmann JS

1 reference

26 April 2018

publication date

1 June 2000

1 reference

26 April 2018

published in

Neuromuscular Disorders

1 reference

26 April 2018

volume

1 reference

26 April 2018

issue

4-5

1 reference

26 April 2018

page(s)

251-256

1 reference

26 April 2018

Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Immunocytochemical studies of cardiac myofibrillogenesis in early chick embryos. I. Presence of immunofluorescent titin spots in premyofibril stages

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Immunocytochemical studies of cardiac myofibrillogenesis in early chick embryos. II. Generation of alpha-actinin dots within titin spots at the time of the first myofibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Myogenesis in the mouse embryo: differential onset of expression of myogenic proteins and the involvement of titin in myofibril assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Expression of dystrophin-associated glycoproteins during human fetal muscle development: a preliminary immunocytochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Titins: giant proteins in charge of muscle ultrastructure and elasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Spatial distribution of "tissue-specific" antigens in the developing human heart and skeletal muscle. II. An immunohistochemical analysis of myosin heavy chain isoform expression patterns in the embryonic heart

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

A new dimension for the human genome project: towards comprehensive expression maps

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Dynamic left/right regionalisation of endogenous myosin light chain 3F transcripts in the developing mouse heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2899%2900107-8

7 January 2021

10.1016/S0960-8966(99)00107-8

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018